HBL-52 Cells

HBL-52 is a human cell line derived from a transitional meningioma grade I, specifically localized at the optic canal. This cell line originates from a female adult patient and exhibits epithelial-like morphology. Meningiomas are typically benign tumors that arise from the meninges, the membranous layers surrounding the brain and spinal cord. The transitional subtype represents a histological category where the tumor cells demonstrate a mixture of fibrous and meningothelial characteristics.

Recent studies have highlighted the responsiveness of HBL-52 cells to resveratrol, a naturally occurring polyphenol with significant anti-inflammatory and anticancer properties. Resveratrol has been found to inhibit proliferation in HBL-52 meningioma cells, suggesting a potential therapeutic role in managing or treating meningiomas, particularly those located in critical areas like the optic canal. This inhibition of cell proliferation highlights the utility of HBL-52 in pharmacological research and drug testing, providing a valuable model for assessing the efficacy of compounds that may influence tumor growth dynamics. Given its origin and benign nature, the HBL-52 cell line is a valuable model for studying meningioma pathogenesis, particularly in understanding the cellular behaviors and molecular mechanisms underlying the development and progression of meningiomas at unique anatomical sites like the optic canal.